- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Form 5 of AZD5718 tablets
Total 17967 results
-
AstraZenecaParexelCompletedCoronary Artery DiseaseUnited Kingdom
-
AstraZenecaParexelCompletedCoronary Artery Disease (CAD)United Kingdom
-
AstraZenecaCompletedCardiovascular Disease | Healthy Male SubjectsUnited Kingdom
-
AstraZenecaCompletedHigh Risk Coronary Artery DiseaseUnited Kingdom
-
Damanhour UniversityCompleted
-
BayerCompletedPharmacokineticsGermany
-
Laboratorios Andromaco S.A.Completed
-
VaxartCompletedNorovirus InfectionUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
AbbVieCompletedHealthy VolunteerUnited States
-
Bristol-Myers SquibbWithdrawn
-
Teva Pharmaceuticals USACompleted
-
Boryung Pharmaceutical Co., LtdWithdrawn
-
Teva Pharmaceuticals USACompleted
-
Teva Pharmaceuticals USACompleted
-
TakedaWithdrawn
-
Teva Pharmaceuticals USACompleted
-
Sironax USA, Inc.CompletedCorona Virus InfectionPakistan, United States, Mexico
-
GlaxoSmithKlineCompletedGastroparesisUnited States, Australia, Belgium, United Kingdom, Canada, Sweden
-
CSL BehringCompletedFatigue | NSCLC | CachexiaCanada, Australia, Russian Federation, Georgia, Serbia, India, New Zealand, Poland, Romania
-
Beijing Tiantan HospitalNeuroDawn Pharmaceutical Co., Ltd.RecruitingIschemic Stroke, AcuteChina
-
Mylan Pharmaceuticals IncCompleted
-
AstraZenecaCLL ConsortiumCompletedB Cell Lymphomas | 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), | Prolymphocytic Leukaemia (PLL)United States
-
Shandong UniversityWest China Second University HospitalNot yet recruitingPersistent Pulmonary Hypertension of the NewbornChina
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompleted
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingThe Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
-
Actavis Inc.Completed
-
VaxartCompletedRespiratory Syncytial Virus (RSV)United States
-
Stallergenes GreerCompletedAsthma | House Dust Mite AllergyFrance, Germany, Poland
-
Mylan Pharmaceuticals IncCompleted
-
Actavis Inc.Completed
-
Actavis Inc.Completed
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedPolycystic Ovary SyndromeNorway
-
Mylan Pharmaceuticals IncCompleted
-
Hartford HospitalSpero TherapeuticsCompleted
-
Ayesha De CostaBoston Children's Hospital; Muhimbili University of Health and Allied Sciences and other collaboratorsCompleted
-
Fujian Cosunter Pharmaceutical Co. LtdCompleted
-
EMSWithdrawn
-
Hacettepe UniversityMerck Sharp & Dohme LLCCompletedChildren | Food Allergy | Bronchial AsthmaTurkey
-
UCB Biopharma SRLWithdrawnEpilepsy | Healthy Participants
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
RVL Pharmaceuticals, Inc.Osmotica Pharmaceutical US LLCWithdrawnMultiple Sclerosis | SpermUnited States
-
JKT Biopharma Co., Ltd.Not yet recruiting
-
Hillel Yaffe Medical CenterCompleted
-
BayerMerck Sharp & Dohme LLC; Duke Clinical Research Institute; Canadian VIGOUR CentreCompletedChronic Heart Failure With Preserved Ejection FractionSpain, United States, Belgium, Singapore, Taiwan, Canada, Japan, Italy, Austria, Bulgaria, Germany, Greece, Israel, Poland, Portugal, Hungary, Russian Federation, Argentina, Colombia, Malaysia, South Africa
-
Assiut UniversityNot yet recruitingBenign Prostatic Hyperplasia
-
Merck Sharp & Dohme LLCTerminated
-
Applied Biology, Inc.CompletedAndrogenetic AlopeciaUnited States, Australia, India, Italy